StockNews.AI
TMCI
StockNews.AI
105 days

Scott+Scott Attorneys at Law LLP Alerts Investors an Action Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

1. A class action lawsuit has been filed against Treace Medical Concepts, Inc. 2. Claims allege misleading statements about business and revenue forecasts. 3. Treace Medical's stock dropped nearly 63% after revenue guidance was lowered. 4. Competition from alternatives affects sales of the Lapiplasty system significantly. 5. Potential class members can seek recovery for losses incurred during the class period.

7m saved
Insight
Article

FAQ

Why Very Bearish?

The substantial stock price drop signals investor distrust and negative outlook. Historical cases, e.g., Enron's collapse, show such lawsuits can devastate stock performance.

How important is it?

The lawsuit directly impacts TMCI’s reputation and investor sentiment, influencing stock price volatility.

Why Short Term?

Immediate investor response to the lawsuit could lead to ongoing stock declines. Past incidents indicate downturns usually persist until resolutions or settlements.

Related Companies

MDXGISRGSYK
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Middle District of Florida against Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b-5) on behalf of all persons other than Defendants who purchased or otherwise acquired Treace Medical securities between May 8, 2023, and May 7, 2024, inclusive (the “Class Period”), and were damaged thereby (the “Class”). The Class Action filed by Scott+Scott is captioned: McCluney v. Treace Medical Concepts, Inc., et al., Case No. 3:25-cv-00390. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Treace Medical is a medical technology company focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. The Company has patented the Lapiplasty, a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint. The Class Action alleges that, during the Class Period, Defendants made misleading statements and omissions regarding the Company’s business, financial condition, and prospects. Specifically, Defendants failed to disclose that: (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System (the “Lapiplasty”); (2) as a result, Treace Medical’s revenue declined and the Company needed to accelerate its plans to offer a product that was an alternative to osteotomy (a surgical procedure that involves cutting and realigning a bone to improve its position or function); and (3) Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. As the truth about Treace Medical’s business reached the market, the price of Treace Medical’s stock suffered significant declines, harming investors. For example, on May 7, 2024, after market hours, when the Company issued a press release reporting, among other things, that it lowered its full-year 2024 revenue guidance from between $220 million and $225 million to between $201 million and $211 million. During the associated earnings call the same day, Defendants revealed competition from minimally invasive osteotomy and Lapiplasty “knockoffs” created headwinds for Lapiplasty growth.   On this news, the Company’s stock price fell $6.95, or nearly 63%, to close at $4.17 per share on May 8, 2024, on unusually high trading volume. ARE YOU A POTENTIAL CLASS MEMBER ELIGIBLE TO RECOVER? CLICK HERE If you purchased Treace Medical securities during the Class Period and were damaged thereby, you are a member of the “Class” and may be able to seek appointment as lead plaintiff. If you wish to apply to be lead plaintiff, a motion on your behalf must be filed with the U.S. District Court for the Middle District of Florida no later than June 10, 2025. The lead plaintiff is a court-appointed representative for absent class members of the Class. You do not need to seek appointment as lead plaintiff to share in any Class recovery in the Class Action. If you are a Class member and there is a recovery for the Class, you can share in that recovery as an absent Class member. If you wish to apply to be lead plaintiff, please contact attorney Nicholas Bruno at (888) 398-9312 or at nbruno@scott-scott.com. CLICK HERE TO FIND OUT IF YOU CAN RECOVER YOUR LOSSES About Scott+Scott Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoing, including securities law and shareholder violations. With more than 100 attorneys in eight offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been repeatedly recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. This may be considered Attorney Advertising. CONTACT:Nicholas BrunoScott+Scott Attorneys at Law LLP230 Park Avenue, 24th Floor, New York, NY 10169(888) 398-9312nbruno@scott-scott.com

Related News